Hologic, Inc. revised revenue results for the First Quarter of Fiscal 2023 . The Company expects to report total revenues of approximately $1,074.2 million, a decrease of (27.0%) compared to the prior year period, or (25.1%) in constant currency. These preliminary results are higher than the Company's most recent revenue guidance range of $940 to $990 million, which was provided on October 31, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
77.69 USD | +1.57% |
|
+4.84% | +8.73% |
Jul. 02 | Evercore ISI Adjusts Price Target on Hologic to $76 From $78, Maintains In-line Rating | MT |
Jun. 27 | Stephens Initiates Coverage on Hologic With Overweight Rating, $87 Price Target | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.73% | 17.85B | |
+3.26% | 207B | |
+6.55% | 182B | |
+31.66% | 157B | |
+34.32% | 113B | |
+5.13% | 66.91B | |
+19.33% | 55.95B | |
-3.30% | 47.01B | |
-4.84% | 38.17B | |
+3.83% | 36.49B |
- Stock Market
- Equities
- HOLX Stock
- News Hologic, Inc.
- Hologic, Inc. Revises Revenue Results for the First Quarter of Fiscal 2023